Insulet
PODD
#1049
Rank
HK$166.85 B
Marketcap
HK$2,370
Share price
-3.62%
Change (1 day)
13.84%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): HK$2.83 Billion

According to Insulet's latest financial reports the company's current earnings are HK$2.52 Billion. In 2024 the company made an earning of HK$2.66 Billion, an increase over its 2023 earnings that were of HK$1.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$2.83 B6.06%
2024 HK$2.66 B36.72%
2023 HK$1.95 B481.9%
2022 HK$0.33 B-45.24%
2021 HK$0.61 B43.35%
2020 HK$0.42 B18.51%
2019 HK$0.36 B41.16%
2018 HK$0.25 B-711.95%
2017 -HK$41.75 Million-56.85%
2016 -HK$96.77 Million-79.31%
2015 -HK$0.47 Billion63.85%
2014 -HK$0.29 Billion31.04%
2013 -HK$0.22 Billion-21.96%
2012 -HK$0.28 Billion
2010 -HK$0.27 Billion-42.38%
2009 -HK$0.47 Billion-33.56%
2008 -HK$0.7 Billion65.93%
2007 -HK$0.42 Billion209.75%
2006 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
HK$0.97 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$1.6 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$7.61 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.35 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$49.82 B 1,659.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$175.18 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA